Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Indoco Remedies's quick ratio for the quarter that ended in Jun. 2026 was 0.00.
Indoco Remedies has a quick ratio of 0.00. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Indoco Remedies's Quick Ratio or its related term are showing as below:
BOM:532612'
s Quick Ratio Range Over the Past 10 Years
Min: 0.67 Med: 0.86 Max: 1.15
Current: 0.75
During the past 13 years, Indoco Remedies's highest Quick Ratio was 1.15. The lowest was 0.67. And the median was 0.86.
BOM:532612's Quick Ratio is ranked worse than 78.38% of 999
companies
in the Drug Manufacturers industry
Industry Median: 1.44
vs BOM:532612: 0.75
Indoco Remedies (BOM:532612) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Indoco Remedies Quick Ratio Related Terms
Indoco Remedies Quick Ratio Historical Data
* Premium members only.
The historical data trend for Indoco Remedies's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indoco Remedies Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Indoco Remedies's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Indoco Remedies's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indoco Remedies (BOM:532612) has a Quick Ratio of 0.00 as of Jun. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Indoco Remedies and its competitors. Over the past decade, Indoco Remedies' Quick Ratio has ranged from 0.67 to 1.15. According to the industry distribution chart, Indoco Remedies ranks #783 out of 999 companies in the Drug Manufacturers industry, placing it in the top 78.4%.
Is Indoco Remedies' Quick Ratio too high?
Indoco Remedies' current Quick Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 1.15. Based on the distribution chart, Indoco Remedies ranks #783 out of 999 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Indoco Remedies has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indoco Remedies' Quick Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Indoco Remedies ranks #783 out of 999 companies for Quick Ratio. This places Indoco Remedies in the lower half of its industry. The industry median Quick Ratio is 1.44. Historically, Indoco Remedies' own Quick Ratio has ranged from 0.67 to 1.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.44, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Indoco Remedies and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indoco Remedies's current Quick Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indoco Remedies stock overvalued right now?
Based on GuruFocus' analysis, Indoco Remedies (BOM:532612) is currently considered Possible Value Trap. The stock's GF Value™ is ₹341.61, compared to a current price of ₹222.85 — trading 34.8% below its estimated fair value. The current Quick Ratio is 0.00. Indoco Remedies' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Indoco Remedies (BOM:532612), the current Quick Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indoco Remedies (BOM:532612) Overvalued in 2026?
Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued.
The current stock price of ₹222.85 is trading 34.8% below its estimated GF Value™ of ₹341.61.
GuruFocus considers Indoco Remedies to be Possible Value Trap.
Key valuation signals for BOM:532612:
Quick Ratio: 0.00
GF Value™: ₹341.61 vs. price of ₹222.85 (34.8% below fair value)
No single metric tells the full story. See the BOM:532612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
65GF Score
Get the complete analysis for BOM:532612
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532612 has been successfully added to your 
